Risk Factors for Repeatedly Reactive HIV-1 EIA and Indeterminate Western Blots
- 23 May 1994
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 154 (10) , 1129-1137
- https://doi.org/10.1001/archinte.1994.00420100115015
Abstract
Objective: Causes of indeterminate results of Western blot testing (IWB) for human immunodeficiency virus (HIV) type 1 include seroconversion, HIV-2 cross-reactivity, and autoimmune disease, but most IWB results remain unexplained. This case-control study assessed risk factors for IWB results, including early HIV infection, other retroviral infection, autoantibodies, and other medical conditions. Design: Prospective study to determine HIV seroconversion rate, with a case-control design to assess other risk factors for IWB. Cases (persons with one or more repeatedly reactive HIV-1 enzyme immunoassay with IWB), their current sexual partners, and controls (persons with negative enzyme immunoassay and Western blot results) were recruited from blood banks, health department and prenatal clinics, and private providers in Washington and Oregon. Results: Of 244 cases enrolled, 206 were followed up for 6 months or longer, and six (3.0%; 95% confidence interval [CI], 0.7% to 5.3%) with recent HIV risk behaviors seroconverted. The Western blot banding patterns differed among groups; cases usually had p17 or p24 bands, while controls and cases' sexual partners usually had polymerase bands. Conditional logistic regression indicated that independent risk factors for IWB among male cases and controls were a tetanus booster in the past 2 years (odds ratio, 3.2; 95% CI, 1.2 to 8.6) and sexual contact with a prostitute (odds ratio, 3.0; 95% CI, 1.0 to 9.5). Independent risk factors for women were parity (odds ratio, 1.2;95%CI, 1.02 to 1.4) and autoantibodies, either rheumatoid factor or antinuclear antibodies (odds ratio, 2.3; 95% CI, 1.03 to 5.6). No cross-reactivity was detected with HIV-2, human T-lymphotrophic virus type 1, feline immunodeficiency or feline leukemia, or bovine immunodeficiency viruses. Conclusions: Evaluation of persons with reactive HIV-1 enzyme immunoassays and IWB should include an assessment of HIV risk and other possible risk factors, such as alloimmunization (ie, parity or recent immunization) or autoantibodies (ie, antinuclear antibodies and rheumatoid factor). The relationship of IWB among men who reported sex with prostitutes is intriguing and warrants further study. (Arch Intern Med. 1994;154:1129-1137)This publication has 10 references indexed in Scilit:
- False-Positive ELISA for Human Immunodeficiency Virus after Influenza VaccinationThe Journal of Infectious Diseases, 1993
- Human immunodeficiency virus type 2 infection in the United States. Epidemiology, diagnosis, and public health implicationsJAMA, 1992
- FOLLOWING UP INDETERMINATE HIV-1 WESTERN BLOTSThe Lancet, 1989
- Update: HIV-2 Infection—United StatesPublished by American Medical Association (AMA) ,1989
- The Case for Wider Use of Testing for HIV InfectionNew England Journal of Medicine, 1989
- Follow‐up testing and notification of anti‐HIV Western blot atypical (indeterminant) donorsTransfusion, 1988
- Interpretation of Antibodies Reacting Solely with Human Retroviral Core ProteinsNew England Journal of Medicine, 1988
- HTLV-III Seropositivity in 1971–1972 Parenteral Drug Abusers — A Case of False Positives or Evidence of Viral Exposure?New England Journal of Medicine, 1986
- HLA antibodies as a cause of false‐positive reactions in screening enzyme immunoassays for antibodies to human T‐lymphotropic virus Type IIITransfusion, 1986
- Screening Test for HTLV-III (AIDS Agent) AntibodiesJAMA, 1985